NK
E2230237
UNEXPLORED
NK is the stock ticker symbol for NantKwest, a biotechnology company focused on developing natural killer (NK) cell-based immunotherapies for cancer and infectious diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| NK canonical | 2 |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.